110 related articles for article (PubMed ID: 26402624)
1. Peripherally Applied Synthetic Tetrapeptides HAEE and RADD Slow Down the Development of Cerebral β-Amyloidosis in AβPP/PS1 Transgenic Mice.
Tsvetkov PO; Cheglakov IB; Ovsepyan AA; Mediannikov OY; Morozov AO; Telegin GB; Kozin SA
J Alzheimers Dis; 2015; 46(4):849-53. PubMed ID: 26402624
[TBL] [Abstract][Full Text] [Related]
2. Clioquinol reduces zinc accumulation in neuritic plaques and inhibits the amyloidogenic pathway in AβPP/PS1 transgenic mouse brain.
Wang T; Wang CY; Shan ZY; Teng WP; Wang ZY
J Alzheimers Dis; 2012; 29(3):549-59. PubMed ID: 22269164
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
Hansen HH; Fabricius K; Barkholt P; Kongsbak-Wismann P; Schlumberger C; Jelsing J; Terwel D; Termont A; Pyke C; Knudsen LB; Vrang N
PLoS One; 2016; 11(7):e0158205. PubMed ID: 27421117
[TBL] [Abstract][Full Text] [Related]
4. Intracerebral Injection of Metal-Binding Domain of Aβ Comprising the Isomerized Asp7 Increases the Amyloid Burden in Transgenic Mice.
Kulikova AA; Cheglakov IB; Kukharsky MS; Ovchinnikov RK; Kozin SA; Makarov AA
Neurotox Res; 2016 May; 29(4):551-7. PubMed ID: 26842600
[TBL] [Abstract][Full Text] [Related]
5. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
6. Intranasal TAT-haFGF Improves Cognition and Amyloid-β Pathology in an AβPP/PS1 Mouse Model of Alzheimer's Disease.
Lou G; Zhang Q; Xiao F; Xiang Q; Su Z; Huang Y
J Alzheimers Dis; 2016; 51(4):985-90. PubMed ID: 26890786
[TBL] [Abstract][Full Text] [Related]
7. Nitration of tyrosine 10 critically enhances amyloid β aggregation and plaque formation.
Kummer MP; Hermes M; Delekarte A; Hammerschmidt T; Kumar S; Terwel D; Walter J; Pape HC; König S; Roeber S; Jessen F; Klockgether T; Korte M; Heneka MT
Neuron; 2011 Sep; 71(5):833-44. PubMed ID: 21903077
[TBL] [Abstract][Full Text] [Related]
8. Stromal cell-derived factor 1α decreases β-amyloid deposition in Alzheimer's disease mouse model.
Wang Q; Xu Y; Chen JC; Qin YY; Liu M; Liu Y; Xie MJ; Yu ZY; Zhu Z; Wang W
Brain Res; 2012 Jun; 1459():15-26. PubMed ID: 22560596
[TBL] [Abstract][Full Text] [Related]
9. Chinese Herbal Medicine Xueshuantong Enhances Cerebral Blood Flow and Improves Neural Functions in Alzheimer's Disease Mice.
Huang Y; Guo B; Shi B; Gao Q; Zhou Q
J Alzheimers Dis; 2018; 63(3):1089-1107. PubMed ID: 29710701
[TBL] [Abstract][Full Text] [Related]
10. Brain Amyloidosis and BDNF Deficiency Have Opposite Effects on Brain Volumes in AβPP/PS1 Mice Both in vivo and ex vivo.
Kärkkäinen E; Lahtinen HM; Närväinen J; Gröhn O; Tanila H
J Alzheimers Dis; 2015; 46(4):929-46. PubMed ID: 26402627
[TBL] [Abstract][Full Text] [Related]
11. An Optimized Combination of Ginger and Peony Root Effectively Inhibits Amyloid-β Accumulation and Amyloid-β-Mediated Pathology in AβPP/PS1 Double-Transgenic Mice.
Lim S; Choi JG; Moon M; Kim HG; Lee W; Bak HR; Sung H; Park CH; Kim SY; Oh MS
J Alzheimers Dis; 2016; 50(1):189-200. PubMed ID: 26639976
[TBL] [Abstract][Full Text] [Related]
12. Treatment with D3 removes amyloid deposits, reduces inflammation, and improves cognition in aged AβPP/PS1 double transgenic mice.
van Groen T; Kadish I; Funke SA; Bartnik D; Willbold D
J Alzheimers Dis; 2013; 34(3):609-20. PubMed ID: 23271316
[TBL] [Abstract][Full Text] [Related]
13. Memory Improvement in the AβPP/PS1 Mouse Model of Familial Alzheimer’s Disease Induced by Carbamylated-Erythropoietin is Accompanied by Modulation of Synaptic Genes.
Armand-Ugón M; Aso E; Moreno J; Riera-Codina M; Sánchez A; Vegas E; Ferrer I
J Alzheimers Dis; 2015; 45(2):407-21. PubMed ID: 25790933
[TBL] [Abstract][Full Text] [Related]
14. High order W02-reactive stable oligomers of amyloid-β are produced in vivo and in vitro via dialysis and filtration of synthetic amyloid-β monomer.
Robb E; Perez K; Hung LW; Masters CL; Barnham KJ; Cherny RA; Bush AI; Adlard PA; Finkelstein DI
J Alzheimers Dis; 2015; 44(1):69-78. PubMed ID: 25182735
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease.
He J; Luo H; Yan B; Yu Y; Wang H; Wei Z; Zhang Y; Xu H; Tempier A; Li X; Li XM
Neurobiol Aging; 2009 Aug; 30(8):1205-16. PubMed ID: 18079026
[TBL] [Abstract][Full Text] [Related]
16. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA
J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075
[TBL] [Abstract][Full Text] [Related]
17. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS
J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767
[TBL] [Abstract][Full Text] [Related]
18. FK506 reduces amyloid plaque burden and induces MMP-9 in AβPP/PS1 double transgenic mice.
Hong HS; Hwang JY; Son SM; Kim YH; Moon M; Inhee MJ
J Alzheimers Dis; 2010; 22(1):97-105. PubMed ID: 20847451
[TBL] [Abstract][Full Text] [Related]
19. Chronic allopregnanolone treatment accelerates Alzheimer's disease development in AβPP(Swe)PSEN1(ΔE9) mice.
Bengtsson SK; Johansson M; Bäckström T; Wang M
J Alzheimers Dis; 2012; 31(1):71-84. PubMed ID: 22495347
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulation of AβPP processing alleviates amyloid-β-related pathology in Alzheimer's disease transgenic mice.
Arbel-Ornath M; Becker M; Rabinovich-Toidman P; Gartner M; Solomon B
J Alzheimers Dis; 2010; 22(2):469-82. PubMed ID: 20847413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
